The National Law Review
Coverage by The National Law Review as tracked by Newsylist.
Remote-Patient Monitoring Companies Dodge Medicare Shift—For Now
There's new guidance on menopause symptoms like hot flashes. What women need to know
Trump's green card curbs test Indian tech workers' American dream
EXCLUSIVE: Social Security begins sending new $1,000 Trump Account notices to parents of newborns
After A Year Of Layoffs, Disney Finds $180 Million For Recruits From Bankrupt Character.AI
Start-Up Claims to Use A.I.-Created Viruses to Treat a Patient
How to prevent osteoporosis, from training to eating calcium-rich food
Kennedy tries to score one more win for MAHA ahead of midterms
CCC Intelligent Solutions agrees to $6.1 billion take-private deal with GTCR, Elliott
How a Controversial Hepatitis B Study Was Funded by the CDC Amid a Global Swirl of Criticism
FERC rejects most of PJM’s large load interconnection plan
Nvidia, AMD, Google, and Meta team up on global blueprint for data center design
Biotech's most exciting startups of 2026: Meet this year's Endpoints 11
Guggenheim Staff Face SEC Interviews in Probe of Walter’s Empire
There’s a Myth About Low Testosterone That Is Spreading Among Young Men. Uh, Yikes.
Exclusive | Corporate America Cut Big Checks to Trump. Now CEOs Fear Subpoenas Are Coming.
Trump Administration Wants Billion-Dollar Businesses to Qualify as ‘Small’
4 Things Women over 50 Should Do Every Day
California minimum wage will rise again in 2027. Here’s the new rate
5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
Plug-In Solar Panels Are Starting to Sprout in U.S. Backyards
5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
Made by AI? EU tells firms to stick a label on it from Sunday
13 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
FDA staff flags data concerns about Capricor's therapy; shares plunge
Capricor Therapeutics shares are plummeting after FDA staff disputed the company's claims of Phase 3 success for its DMD cell therapy.
Traders Are Getting a New Tool to Wager on the Biggest US Stocks
CME Group has relaunched cash-settled single-stock futures for more than 50 major US companies, expanding leveraged trading options for retail investors.
The U.S. Is Pulling Back on Energy Efficiency Just as Prices Are Rising
The U.S. Department of Energy is proposing changes to appliance efficiency standards amid a period of rising prices.
The Next Wave Of Peptides Could Be Here; What Does It Mean For Lilly, Novo?
5 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.
Medicine is Moving From Calendars to Clocks
Medical research is shifting focus from chronological age to biological aging clocks to better understand human health and lifespan.
Campaign text messages could soon get more effective
Political campaigns are leveraging AI bots and increased funding to enhance the effectiveness of voter outreach via text messages.
California's dairy industry panics over August recycling deadline
12 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
How to handle the heatwave mosquito surge
As heatwaves drive a surge in insect activity, homeowners are seeking effective methods to prevent mosquito bites and manage backyard infestations.
N.J. campaigns brace for voter data shutdown under new law
5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
Bruce Springsteen Says He’s a ‘Patriot’ for Standing Up to Trump: ‘I Believe in Critical Patriotism’
Bruce Springsteen defines his opposition to President Trump as 'critical patriotism' coinciding with America's 250th birthday.
SEC opens ETF rule review following crypto fund surge, prediction markets push
DEA Resists Testimony From Agency Official Linked To Report On Marijuana's Harms During Rescheduling Hearing
JPMorgan Chase unveils $50 billion buyback, Goldman Sachs raises dividend after Fed stress test
JPMorgan Chase and Goldman Sachs announce plans for buybacks and dividend increases after passing Fed stress test
A Solution to A.I.’s Growing Power Demand: Homes
Homes may help solve AI's growing power demand